MAP
Microba Life Sciences Limited
1 day chart
About MAP
Microba Life Sciences Limited is a precision microbiome company with leading technology developed at the University of Queensland. Microba provide its gut microbiome testing services globally through two service types - Personal Testing and Research Testing.
Buy Australian shares starting with MAP. Invest today with a CHESS-sponsored investing platform!
Market Capitalisation
$107M
Price-earnings ratio
-8.93
Dividend yield
NaN%
High today
$0.36
Low today
$0.34
Open price
$0.35
52-week high
$0.45
52-week low
$0.14
Announcements
MAP FAQs
Can I buy MAP shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake platform allows you to buy MAP shares and over 8,000 stocks and ETFs across the ASX and Wall St.
How much is one share of Microba Life Sciences Limited?
One share of Microba Life Sciences Limited is valued at $0.36.
What is the ticker symbol for Microba Life Sciences Limited?
The ticker symbol for Microba Life Sciences Limited is MAP.
How do I buy MAP shares in Australia?
To buy MAP stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in MAP
What is the 52-week high for Microba Life Sciences Limited stock?
The Microba Life Sciences Limited 52-week high stock price is $0.45.
What is the 52-week low for Microba Life Sciences Limited stock?
The Microba Life Sciences Limited 52-week low stock price is $0.14.
What is the market capitalisation of Microba Life Sciences Limited MAP?
As of 30/09/2023 Microba Life Sciences Limited has a market cap of $107M.
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.